Tierney David S
SEC CIK 1292636 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZVRA | ZEVRA THERAPEUTICS, INC. | Dir | 10.8K | $45.1K | — | 3 | 2021-11-30 | 2023-03-09 |
Most active insiders at ZVRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McFarlane Neil F. | Pres, CEO, Dir | — | $1.19M |
| 2 | Thompson Rahsaan | Chief Legal, Compliance, Sec | — | $969.4K |
| 3 | Watton Corey Michael | Dir | — | $138.4K |
| 4 | Schafer Joshua | CCO | — | $126.3K |
| 5 | Sangiovanni Timothy J. | SVP, Fin, Corp Ctrl | — | $43.0K |
| 6 | Quartel Adrian W | Chief Medical Off | — | $40.0K |
| 7 | Bode John B | Dir | — | — |
| 8 | Clifton R. LaDuane | Former CFO, Treas | — | — |
Tierney David S made no open-market trades at ZVRA in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-13 | 2023-03-09 | ZVRA | ZEVRA THERAPEUTICS, INC. | Tierney David S | Dir | P - Purchase | $4.15 | +5,000 | 10.8K | +86% | +$20.8K | |
| 2022-05-26 | 2022-05-25 | ZVRA | ZEVRA THERAPEUTICS, INC. | Tierney David S | Dir | P - Purchase | $4.39 | +2,000 | 5,835 | +52% | +$8,780 | |
| 2021-11-30 | 2021-11-30 | ZVRA | ZEVRA THERAPEUTICS, INC. | Tierney David S | Dir | P - Purchase | $7.79 | +2,000 | 3,835 | +109% | +$15.6K |
Purchase Sale Sale after option exercise All abbreviations